New Leadership, New Policies at FDA
Jill Weschler
Applied Clinical Trials, Apr 1, 2004 McClellan shifts to head Medicare after delivering new proposals to block counterfeits, add bar codes, and assess drug imports.
For full artical Click Here
Jill Weschler
Applied Clinical Trials, Apr 1, 2004 McClellan shifts to head Medicare after delivering new proposals to block counterfeits, add bar codes, and assess drug imports.
For full artical Click Here